Clinical Trials Market is estimated to be US$ 14.36 billion by 2030 with a CAGR of 5.3% during the forecast period

Download Sample

Published Date: March 2024

Clinical Trials Market accounted for US$ 42.4 billion in 2020 and is estimated to be US$ 74.2 billion by 2030 and is anticipated to register a CAGR of 5.5% Clinical trials are tests that are carried out under the auspices of clinical research and adhere to a strict methodology. Clinical trials are used to assess the efficacy and safety of pharmaceuticals or medical devices by observing how they affect large groups of people. Government health institutions, such as the National Institutes of Health (NIH), researchers linked with a hospital or university medical school, independent researchers, or private enterprise undertake clinical research trials. These tests are generally used to gather information about the safety and efficacy of newly produced pharmaceuticals. The results of the clinical trials are required for drug approval and market introduction. Clinical trials are divided into three phases (I, II, and III), depending on a variety of circumstances.

The report "Clinical Trials Market, By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Trials, Observational Trials, and Expanded Access Trials), By Indication (Autoimmune, Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental Disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology and Others), and, By Region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa)-Trends, Analysis and Forecast till 2030’’

Key Highlights:

In August 2020, NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients.
In November 2021, EPAM Systems has announced the launch of its new Digital Clinical Trials (DCT) platform, which is powered by Microsoft cloud services and focuses on patients. The DCT platform may enable sophisticated hybrid or decentralised clinical trials through a virtual, outcome-driven experience, connecting clinical research organisations, patients, and healthcare professionals.

Analyst View:

As a result of globalization, emerging countries are investing more in new product development, resulting in a rise in the clinical trials industry. The increasing occurrence of unusual and novel disease cases is one factor driving the clinical target market forward. The rising number of patients with a certain ailment encourages biopharmaceutical companies to invest more in clinical trials, resulting in the clinical trials market's expansion. Furthermore, the introduction of innovative pharmaceuticals such as personalised medicine and the increased demand for CROs to conduct clinical trials are likely to propel the clinical trials market globally. In addition, the target market's expansion is hampered by a scarcity of qualified clinical research personnel.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Clinical Trials Market, By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Trials, Observational Trials, and Expanded Access Trials), By Indication (Autoimmune, Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental Disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology and Others), and, By Region (North America, Asia Pacific, Europe, Latin America and Middle East & Africa)-Trends, Analysis and Forecast till 2030”

Key Market Insights from the report:

Clinical Trials Market accounted for US$ 42.4 billion in 2020 and is estimated to be US$ 74.2 billion by 2030 and is anticipated to register a CAGR of 5.5% .Clinical Trials market is segmented into phase, study design, indication and region.

Based on Phase, the Clinical Trials Market is segmented into Phase I, Phase II, Phase III, Phase IV.
Based on Study Design, the Clinical Trials Market is segmented into Interventional Trials, Observational Trials, and Expanded Access Trials.
Based on Indication, the Clinical Trials Market is segmented into Autoimmune, Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental Disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology and Others.
By Region, the Clinical Trials Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of Clinical Trials Market:

The key players in the Clinical Trials market includes Eli Lilly and Company, Novo Nordisk A/S, Ranbaxy Laboratories Ltd, Sanofi Aventis A.S., Roche Group, Biocair International Ltd, Catalent Pharma Solutions, PAREXEL International Corporation, Thermo Fischer Scientific, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period

Market Purview

Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
  - Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Estimation
- Top-Down Approach
  - Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
  - Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions